|
Hyperlipoproteinemia Type II
|
D006938 |
[A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
, Type IIb hyperlipoproteinemia is caused by mutation in the receptor-binding domain of APOLIPOPROTEIN B-100 which is a major component of LOW-DENSITY LIPOPROTEINS and VERY-LOW-DENSITY LIPOPROTEINS resulting in reduced clearance of these lipoproteins. It is characterized by both hypercholesterolemia and HYPERTRIGLYCERIDEMIA (combined hyperlipidemia).
, Hypercholesterolemia that is caused by mutation in the LOW DENSITY LIPOPROTEIN RECEPTOR gene. This receptor defect prevents LDL binding to the cell membrane and uptake of cholesterol which normally suppresses further cholesterol synthesis.
] |
|
Chorionic Villi Sampling
|
E01.370.225.998.054.149 |
|
|
Hyperemesis Gravidarum
|
D006939 |
[Intractable VOMITING that develops in early PREGNANCY and persists. This can lead to DEHYDRATION and WEIGHT LOSS.
] |
|
Hoodia
|
D000068798 |
[A genus in the dogbane family (Apocynaceae) used in TRADITIONAL MEDICINE for appetite-suppressant properties.
] |
|
AIDS-Associated Nephropathy
|
C20.673.480.050 |
|
|
Hypercalcemia
|
D006934 |
[Abnormally high level of calcium in the blood.
] |
|
Systematic Review
|
D000078182 |
[A review of primary literature in health and health policy that attempts to identify, appraise, and synthesize all the empirical evidence that meets specified eligibility criteria to answer a given research question. Its conduct uses explicit methods aimed at minimizing bias in order to produce more reliable findings regarding the effects of interventions for prevention, treatment, and rehabilitation that can be used to inform decision making.
] |
|
Prasugrel Hydrochloride
|
D000068799 |
[A piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANGINA and MYOCARDIAL INFARCTION, as well as in those undergoing PERCUTANEOUS CORONARY INTERVENTIONS.
] |
|
Hypercapnia
|
D006935 |
[A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
] |
|
Oxindoles
|
D000078183 |
[Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl and a carbonyl at the pyrrole ring typically at the 2-position.
] |
|
Hypercementosis
|
D006936 |
[A regressive change of teeth characterized by excessive development of secondary cementum on the tooth surface. It may occur on any part of the root, but the apical two-thirds are most commonly affected. (Dorland, 27th ed)
] |
|
Hypercholesterolemia
|
D006937 |
[A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
] |
|
Hyperalgesia
|
D006930 |
[An increased sensation of pain or discomfort produced by minimally noxious stimuli due to damage to soft tissue containing NOCICEPTORS or injury to a peripheral nerve.
] |
|
Urinary Calculi
|
C13.351.968.967.500 |
|
|
Urolithiasis
|
C13.351.968.967 |
|
|
Hyperbaric Oxygenation
|
D006931 |
[The therapeutic intermittent administration of oxygen in a chamber at greater than sea-level atmospheric pressures (three atmospheres). It is considered effective treatment for air and gas embolisms, smoke inhalation, acute carbon monoxide poisoning, caisson disease, clostridial gangrene, etc. (From Segen, Dictionary of Modern Medicine, 1992). The list of treatment modalities includes stroke.
] |
|
Hyperbilirubinemia
|
D006932 |
[A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine.
] |
|
Empty Sella Syndrome
|
C10.228.140.617.738.200 |
|
|
Hyperbilirubinemia, Hereditary
|
D006933 |
[Inborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood.
] |
|
Hospitals, Satellite
|
N02.278.421.530 |
|